The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program… (continue)
Month: June 2016
“Rocky mountain high” is a common phrase in Denver, CO but that transient high so sought after by pot-smokers may be doing long-term harm to their brains. Researchers in Switzerland track the marijuana use of 3,400 users over 25 years and tested them on memory, mental processing speed and executive function. The results are concerning. For each five years of pot use, 50% of smokers remembered one fewer of fifteen words from a numbered list. That may seem like a small difference, but it is significant and may indicate direct toxic effects to neurons.